{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T13:29:13Z","timestamp":1777555753825,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,26]],"date-time":"2016-10-26T00:00:00Z","timestamp":1477440000000},"content-version":"vor","delay-in-days":2582,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1038\/mt.2009.169","type":"journal-article","created":{"date-parts":[[2009,8,13]],"date-time":"2009-08-13T06:47:36Z","timestamp":1250146056000},"page":"1822-1829","source":"Crossref","is-referenced-by-count":37,"title":["Phase I Study of H5.020CMV.PDGF-\u03b2 to Treat Venous Leg Ulcer Disease"],"prefix":"10.1016","volume":"17","author":[{"given":"David J","family":"Margolis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee M","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryte","family":"Papadopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer C","family":"Filip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie A","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachin S","family":"Vaikunth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy M","family":"Crombleholme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2009.169_bib1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/000331979704800111","article-title":"Socioeconomic impact of chronic venous insufficiency and leg ulcers","volume":"48","author":"Ruckley","year":"1997","journal-title":"Angiology"},{"key":"10.1038\/mt.2009.169_bib2","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jaad.2006.05.048","article-title":"The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology","volume":"55","author":"Bickers","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/mt.2009.169_bib3","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.CIR.48.4.839","article-title":"Venous thromboembolism and other venous disease in the Tecumseh community health study","volume":"48","author":"Coon","year":"1973","journal-title":"Circulation"},{"key":"10.1038\/mt.2009.169_bib4","first-page":"17","article-title":"Leg ulcer epidemiology","volume":"544","author":"Hallbook","year":"1988","journal-title":"Acta Chir Scand"},{"key":"10.1038\/mt.2009.169_bib5","doi-asserted-by":"crossref","first-page":"38S","DOI":"10.1111\/1523-1747.ep12388556","article-title":"Chronic cutaneous ulcers: etiology and epidemiology","volume":"102","author":"Phillips","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1038\/mt.2009.169_bib6","first-page":"1047","article-title":"A systematic review of compression treatment for venous leg ulcers","volume":"3385","author":"O'Meara","year":"2009","journal-title":"BMJ"},{"key":"10.1038\/mt.2009.169_bib7","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1136\/bmj.305.6862.1119","article-title":"Venous leg ulcers: a prognostic index to predict time to healing","volume":"305","author":"Skene","year":"1992","journal-title":"BMJ"},{"key":"10.1038\/mt.2009.169_bib8","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/archderm.134.3.293","article-title":"Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Human Skin Equivalent Investigators Group","volume":"134","author":"Falanga","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1038\/mt.2009.169_bib9","unstructured":"Clark RAF (1996). Wound repair: overview and general considerations In: Clark RAF (ed). The Molecular and Cellular Biology of Wound Repair, 2 edn. Plenum: New York. pp. 3\u201350"},{"key":"10.1038\/mt.2009.169_bib10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1126\/science.276.5309.75","article-title":"Wound healing\u2014aiming for perfect skin regeneration","volume":"276","author":"Martin","year":"1997","journal-title":"Science"},{"key":"10.1038\/mt.2009.169_bib11","first-page":"1261","article-title":"Growth factors in porcine full and partial thickness burn repair. Differing targets and effects of keratinocyte growth factor, platelet-derived growth factor-BB, epidermal growth factor, and neu differentiation factor","volume":"147","author":"Danilenko","year":"1995","journal-title":"Am J Pathol"},{"key":"10.1038\/mt.2009.169_bib12","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1146\/annurev.med.46.1.467","article-title":"Pharmacologic enhancement of wound healing","volume":"46","author":"Pierce","year":"1995","journal-title":"Annu Rev Med"},{"key":"10.1038\/mt.2009.169_bib13","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1172\/JCI118169","article-title":"Detection of platelet-derived growth factor (PDGF)-AA in actively healing human wounds treated with recombinant PDGF-BB and absence of PDGF in chronic nonhealing wounds","volume":"96","author":"Pierce","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2009.169_bib14","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/1523-1747.ep12319188","article-title":"Reduced expression of PDGF and PDGF receptors during impaired wound healing","volume":"109","author":"Beer","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1038\/mt.2009.169_bib15","doi-asserted-by":"crossref","first-page":"822","DOI":"10.2337\/diacare.21.5.822","article-title":"Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study","volume":"21","author":"Wieman","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1038\/mt.2009.169_bib16","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1524-4725.1992.tb03514.x","article-title":"Topical use of human recombinant epidermal growth factor (h-EGF) in venous ulcers","volume":"18","author":"Falanga","year":"1992","journal-title":"J Dermatol Surg Oncol"},{"key":"10.1038\/mt.2009.169_bib17","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1046\/j.1524-475x.2000.00460.x","article-title":"Adenoviral-mediated gene transfer in wound healing","volume":"8","author":"Crombleholme","year":"2000","journal-title":"Wound Repair Regen"},{"key":"10.1038\/mt.2009.169_bib18","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1046\/j.1524-475X.1999.00148.x","article-title":"Recombinant adenoviral mediated gene transfer in ischemic impaired wound healing","volume":"7","author":"Liechty","year":"1999","journal-title":"Wound Repair Regen"},{"key":"10.1038\/mt.2009.169_bib19","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1046\/j.1524-475x.2000.00036.x","article-title":"Adenoviral-mediated gene transfer in wound healing: acute inflammatory response in human skin in the SCID mouse model","volume":"8","author":"Sylvester","year":"2000","journal-title":"Wound Repair Regen"},{"key":"10.1038\/mt.2009.169_bib20","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1046\/j.1523-1747.2003.12112.x","article-title":"Stroma formation and angiogenesis by overexpression of growth factors, cytokines, and proteolytic enzymes in human skin grafted to SCID mice","volume":"120","author":"Gruss","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1038\/mt.2009.169_bib21","unstructured":"Guidance for Industry: Chronic Cutaneous Ulcer and Burn Wounds-developing Products for Treatment (2006). Food and Drug Administration. pp. 1\u201318"},{"key":"10.1038\/mt.2009.169_bib22","first-page":"155","article-title":"Expected healing rates for chronic wounds","volume":"12","author":"Kantor","year":"2000","journal-title":"Wounds"},{"key":"10.1038\/mt.2009.169_bib23","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1046\/j.1523-1747.2002.19629.x","article-title":"Surrogate endpoints for the treatment of venous leg ulcers","volume":"119","author":"Gelfand","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1038\/mt.2009.169_bib24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1067-1927.2004.012207.x","article-title":"The accuracy of venous leg ulcer prognostic models in a wound care system","volume":"12","author":"Margolis","year":"2004","journal-title":"Wound Repair Regen"},{"key":"10.1038\/mt.2009.169_bib25","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s11892-004-0049-x","article-title":"Reducing the incidence of foot ulceration and amputation in diabetes","volume":"4","author":"Bartus","year":"2004","journal-title":"Curr Diab Rep"},{"key":"10.1038\/mt.2009.169_bib26","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1046\/j.1524-475X.1999.00208.x","article-title":"Systemic treatment of venous leg ulcers with high doses of pentoxifylline: efficacy in a randomized, placebo-controlled trial","volume":"7","author":"Falanga","year":"1997","journal-title":"Wound Repair Regen"},{"key":"10.1038\/mt.2009.169_bib27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0741-5214(95)70245-8","article-title":"Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic Ulcer Study Group","volume":"21","author":"Steed","year":"1995","journal-title":"J Vasc Surg"},{"key":"10.1038\/mt.2009.169_bib28","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1055\/s-2005-872886","article-title":"Locally applied mononuclear bone marrow cells restore angiogenesis and promote wound healing in a type 2 diabetic patient","volume":"113","author":"Humpert","year":"2005","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1038\/mt.2009.169_bib29","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/hh1301.093953","article-title":"Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease","volume":"89","author":"Vasa","year":"2001","journal-title":"Circ Res"},{"key":"10.1038\/mt.2009.169_bib30","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1172\/JCI8071","article-title":"Origins of circulating endothelial cells and endothelial outgrowth from blood","volume":"105","author":"Lin","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2009.169_bib31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/path.2283","article-title":"CD133: molecule of the moment","volume":"214","author":"Mizrak","year":"2008","journal-title":"J Pathol"},{"key":"10.1038\/mt.2009.169_bib32","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1089\/hum.2004.15.1003","article-title":"Clinical protocol. Phase I trial to evaluate the safety of H5.020CMV.PDGF-b and limb compression bandage for the treatment of venous leg ulcer: trial A","volume":"15","author":"Margolis","year":"2004","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2009.169_bib33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ymgme.2008.12.016","article-title":"Lessons learned from the gene therapy trial for ornithine transcarbamylase deficiency","volume":"96","author":"Wilson","year":"2009","journal-title":"Mol Genet Metab"},{"key":"10.1038\/mt.2009.169_bib34","unstructured":"FDA ICH E9 (1998) E9 Statistical Principles for Clinical Trials www.FDA.gov September"},{"key":"10.1038\/mt.2009.169_bib35","first-page":"1085","article-title":"Sequential changes in histologic pattern and extracellular matrix deposition during the healing of chronic venous ulcers","volume":"141","author":"Herrick","year":"1992","journal-title":"Am J Pathol"},{"key":"10.1038\/mt.2009.169_bib36","unstructured":"Nonradioactive In Situ Hybridization Application Manual http:\/\/www.roche-applied-science.com\/PROD_INF\/MANUALS\/InSitu\/InSi_toc.htm Accessed 5 January 2009"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616321475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616321475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T20:54:51Z","timestamp":1545080091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616321475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S1525001616321475"],"URL":"https:\/\/doi.org\/10.1038\/mt.2009.169","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}